Life Science Financial Executive Joins Management Team
January 26, 2016 (Baltimore, MD) Noxilizer, Inc., the company
advancing a room temperature, NO2-based sterilization and decontamination
process for bio-pharmaceutical and medical device manufacturers
announces David A. Theil as their new Senior Vice President
and Chief Financial Officer (CFO). More.
Theil specializes in private equity funded start-up and middle
market companies in the Life Sciences industry and brings 25+
years of financial, administrative and operational management
experience. Most recently, he worked as interim and contract
CFO in the medical device and clinical diagnostics arenas. Previous
industry employment appointments include: Supernus Pharmaceuticals,
Specialty Pharmaceuticals; Psychiatric Genomics, Biotechnology
R&D Drug Discovery; and IGEN International, Instrumentation
brings experience that is critical to Noxilizer at this stage
of the company," states Lawrence Bruder, President &
CEO. "He has worked in growing companies and understands
the opportunities and challenges."
Theil also worked at Deloitte & Touche, as a Manager of
Emerging Business Markets Group, where he served clients in
biotechnology, communications, healthcare and other middle market
technology companies. Mr. Theil obtained his BSc in Accounting
from the Kelley School of Business at Indiana University, Bloomington
IN, and holds a Delaware CPA certificate.